“The pharma industry is desperately looking forward to agile framework anticipating the desired change on these areas. However, the agile frame work should be understood by the project portfolio and CXO people in right perspective. It will not establish overnight.
Moreover, it requires systematic planning by top management. The initiative should be initiated from the CEO desk with proper detailed execution plan. The critical work will not be reduced but losses, rework, delay, lag time, time consuming processes will be reduced to considerable extend.
This is the value addition agile is bring to the table.
The tasks alignment as per the market demands/fluctuations and concerns/challenges with respect to the safety of the molecule can be better addressed by agile way of working rather than waterfall methodology. People interaction and knowledge is the backbone of agile framework. It is more people oriented than process, but keeps the process authenticity intact.